Paranasal Sinus DiseasesNORANCT04968561
Design of an Augmented Reality System by Integration of CT Scan or MRI Data With Endoscopic Images for Video-assisted Endonasal Endoscopic Surgery
An observational study of Paranasal Sinus Diseases and Nasal Diseases, run by University Hospital, Clermont-Ferrand at 1 site in France.
Trial summary
The gold standard surgical treatment for benign nasosinus pathologies is endoscopic surgery. This surgery has experienced considerable growth over the last 30 years. Nevertheless, these techniques can potentially lead to serious complications, with risks of damaging adjacent structures (orbit, optic nerve, meninge or… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Paranasal Sinus Diseases, Nasal Diseases, Lacrimal Apparatus Diseases
- How many people
- 40 participants
- Where
- 1 siteFrance
- Study dates
- 2 Nov 2020to Oct 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adult patients addmitted in the ENT and Cervico-Facial Surgery department of the Gabriel Montpied University Hospital in Clermont-Ferrand requiring endoscopic sinus surgery
Who may be able to join
- Adult patients
- Admitted in the ENT and Cervico-Facial Surgery department of the Gabriel Montpied University Hospital in Clermont-Ferrand.
- From November 2020 to October 2021,
- Requiring endoscopic sinus surgery
- With good quality imaging (CT scan and/or MRI)
Who cannot join
- Patient under the age of 18
Trial locations and contacts
1 site in 1 country.
France1 site, 1 recruiting
- Recruiting
CHU clermont-ferrand
Clermont-Ferrand
Lise Laclautre
Justine Bécaud
About this study
The gold standard surgical treatment for benign nasosinus pathologies is endoscopic surgery. This surgery has experienced considerable growth over the last 30 years. Nevertheless, these techniques can potentially lead to serious complications, with risks of damaging adjacent structures (orbit, optic nerve, meninge or internal carotid artery). Therefore, improving the safety of these procedures is a fundamental objective. Recently, computer-assisted surgery, allowing endonasal navigation, has emerged. It appears to be an asset for the patient, limiting complications and morbidity, and for the surgeon, improving his comfort and reducing his mental workload. The major pitfall of the current technique is the loss of localisation reliability during the intervention due to the registration process and the presence of two screens (to locate the object on the endoscopic image and on the scan) We would like to propose solutions to these limitations using a device based on augmented reality and 3D reconstructions. It would guide the gesture in endonasal endoscopic surgery by displaying high-risk areas and surgical landmarks in a reliable and precise way.
Read the detailed description
The available literature offers numerous expert and consensus opinions supporting the usefulness and acceptance of endonasal navigation and encouraging development of optimised navigation systems Augmented reality (AR) allows the surgeon to visualise the preoperative imaging information in the form of a projection that is displayed on the endoscopic image screen. This application, used in other surgical fields, is promising. The EnCoV team of the Institut Pascal laboratory has notably developed an innovative functional AR system, in laparoscopy in gynaecological, digestive and urological surgery The feasibility in endonasal surgery has been confirmed in a cadaveric model and its clinical utility shown on various systems. However, the question of accuracy during calibration and during the surgery remains.
We propose a surface registration system based on 3D reconstructions of patient's face and endoscopic images. It would match 3D reconstructions of the patient's images with 3D reconstructions of the CT scan or MRI images. Thus, this device would be able to provide a large number of reference points for precise mapping. Tissue recognition (texture, contours, etc.) processes would allow to display the right information in the right place.
To date, there is no such AR endonasal navigation system. Thus, the technical evolutions developed in laparoscopy by the EnCoV team would be transposed the ENT field in order to optimise endonasal endoscopy.
Outline of the study :
Feasibility study, observational, transversal. Feasibility criterion: To evaluate the feasibility of a device based on AR to guide the gesture in endonasal endoscopic surgery by displaying invisible high-risk areas and surgical landmarks in a reliable and accurate way.
- Development of a questionnaire for AFR and SJORL ENT surgeons in order to assess their needs and the interest of implementing such a navigation
- Study of the feasibility of integrating, in the laboratory, CT scan images with facial and endonasal images filmed in the operating theatre, to form a qualitative clinical study.
- Patients and data acquisition:
- Data acquisition The images will be collected in the operating theatre of the ENT and Cervico-Facial Surgery department of the Gabriel Montpied University Hospital in Clermont-Ferrand. They will be obtained from videos of the face and endonasal anatomy filmed using the endoscope. All these images will be anonymised.
- Duration of inclusion: 12 months (November 2020- October 2021)
- Number of patients: Intermediate stages with analysis every 5 patients for the first 15 patients and then every 10 patients will be realised, adapting the recording methods and algorithms to the results. This will be a progressive process of adjustment and refinement. The methods for recording patient data in the operating theatre will evolve in order to optimise image processing. The annual recruitment capacity is 50 patients; a maximum number of 30 to 40 patients is expected.
- Written consent: prospective collection of the patient's non-opposition
- Duration of each patient's participation: 1 day
- Data processing: This will be a collaborative work with the EnCoV team under the responsibility of Pr A. BARTOLI. The most relevant images will be extracted, corrected and then transformed into a 3D model in order to acquire depth data. The CT scan images will also be transformed into 3D format. These two 3D models (from the patient and from the imaging) will be merged using an algorithm, in order to allow surface registration. The data will first be stored on the EnCoV servers.
- Validation of the navigation system by experimenting it on phantom models made from 3D printing and ex vivo animal models, to form a quantitative preclinical study. In endonasal endoscopy procedures the validity of the display of easily recognisable structures will be checked.
- Keywords
- Endoscopic sinus surgery, Augmented reality, Surgical Navigation system, Computer-assisted surgery, 3D reconstructions
- Medical subject headings
- Paranasal Sinus Diseases, Nose Diseases, Lacrimal Apparatus Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| cohort 1 | Adult patients * Admitted in the ENT and Cervico-Facial Surgery department of the Gabriel Montpied University Hospital in Clermont-Ferrand. * From November 2020 to October 2021, * Requiring endoscopic sinus surgery * With good quality imaging (CT scan and/or MRI) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Target registration error
The feasibility of integrating medical imaging data with endoscopic images will be assessed by the accuracy of the registration obtained, called TRE (Target Registration Error). This is a standard evaluation methodology of a registration between modalities.
Measured: day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Jul 2021
- Study start2 Nov 2020
- Primary completionSep 2021 (estimated)
- Study completionOct 2021 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Paranasal Sinus DiseasesStudies of the same condition, open and under way.
- More trials run by University Hospital, Clermont-FerrandThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Clermont-Ferrand
- Sponsor type
- University, hospital or other
- Collaborators
- Institut Pascal (CNRS 6602/ Université Clermont Auvergne / SIGMA), équipe EnCoV, Collin medical, Audition Conseil, CHU Clermont-Ferrand (Appel d'offre Interne), Bourse Année-Recherche par l'Agence Régionale de Santé Auvergne Rhone Alpes pour Mme Luce COMPAGNONE pour l'année 2020-2021
- Responsible party
- Sponsor
- Investigators
- Justine Bécaud, Principal investigator, University Hospital, Clermont-Ferrand
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04968561
- Sponsor's protocol ID
- 2020 Becaud Nora
- Acronym
- NORA
- Status last verified
- Jul 2021
- First submitted
- 5 Jul 2021
- Last updated
- 20 Jul 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Jul 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Design of an Augmented Reality System by Integration of CT Scan or MRI Data With Endoscopic Images for Video-assisted Endonasal Endoscopic Surgery
- ClinicalTrials.gov ID
- NCT04968561
- Acronym / sponsor ID
- NORA / 2020 Becaud Nora
- Keywords
- Endoscopic sinus surgery, Augmented reality, Surgical Navigation system, Computer-assisted surgery, 3D reconstructions
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- University Hospital, Clermont-FerrandUniversity, hospital or other
- Collaborators
- Institut Pascal (CNRS 6602/ Université Clermont Auvergne / SIGMA), équipe EnCoV, Collin medical, Audition Conseil, CHU Clermont-Ferrand (Appel d'offre Interne), Bourse Année-Recherche par l'Agence Régionale de Santé Auvergne Rhone Alpes pour Mme Luce COMPAGNONE pour l'année 2020-2021
- Study start
- 2 Nov 2020 (actual)
- Primary completion
- Sep 2021 (estimated)
- Study completion
- Oct 2021 (estimated)
- First posted
- 20 Jul 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The gold standard surgical treatment for benign nasosinus pathologies is endoscopic surgery. This surgery has experienced considerable growth over the last 30 years. Nevertheless, these techniques can potentially lead to serious complications, with risks of damaging adjacent structures (orbit, optic nerve, meninge or internal carotid artery). Therefore, improving the safety of these procedures is a fundamental objective. Recently, computer-assisted surgery, allowing endonasal navigation, has emerged. It appears to be an asset for the patient, limiting complications and morbidity, and for the surgeon, improving his comfort and reducing his mental workload. The major pitfall of the current technique is the loss of localisation reliability during the intervention due to the registration process and the presence of two screens (to locate the object on the endoscopic image and on the scan) We would like to propose solutions to these limitations using a device based on augmented reality and 3D reconstructions. It would guide the gesture in endonasal endoscopic surgery by displaying high-risk areas and surgical landmarks in a reliable and precise way.
Detailed description
The available literature offers numerous expert and consensus opinions supporting the usefulness and acceptance of endonasal navigation and encouraging development of optimised navigation systems Augmented reality (AR) allows the surgeon to visualise the preoperative imaging information in the form of a projection that is displayed on the endoscopic image screen. This application, used in other surgical fields, is promising. The EnCoV team of the Institut Pascal laboratory has notably developed an innovative functional AR system, in laparoscopy in gynaecological, digestive and urological surgery The feasibility in endonasal surgery has been confirmed in a cadaveric model and its clinical utility shown on various systems. However, the question of accuracy during calibration and during the surgery remains.
We propose a surface registration system based on 3D reconstructions of patient's face and endoscopic images. It would match 3D reconstructions of the patient's images with 3D reconstructions of the CT scan or MRI images. Thus, this device would be able to provide a large number of reference points for precise mapping. Tissue recognition (texture, contours, etc.) processes would allow to display the right information in the right place.
To date, there is no such AR endonasal navigation system. Thus, the technical evolutions developed in laparoscopy by the EnCoV team would be transposed the ENT field in order to optimise endonasal endoscopy.
Outline of the study :
Feasibility study, observational, transversal. Feasibility criterion: To evaluate the feasibility of a device based on AR to guide the gesture in endonasal endoscopic surgery by displaying invisible high-risk areas and surgical landmarks in a reliable and accurate way.
- Development of a questionnaire for AFR and SJORL ENT surgeons in order to assess their needs and the interest of implementing such a navigation
- Study of the feasibility of integrating, in the laboratory, CT scan images with facial and endonasal images filmed in the operating theatre, to form a qualitative clinical study.
- Patients and data acquisition:
- Data acquisition The images will be collected in the operating theatre of the ENT and Cervico-Facial Surgery department of the Gabriel Montpied University Hospital in Clermont-Ferrand. They will be obtained from videos of the face and endonasal anatomy filmed using the endoscope. All these images will be anonymised.
- Duration of inclusion: 12 months (November 2020- October 2021)
- Number of patients: Intermediate stages with analysis every 5 patients for the first 15 patients and then every 10 patients will be realised, adapting the recording methods and algorithms to the results. This will be a progressive process of adjustment and refinement. The methods for recording patient data in the operating theatre will evolve in order to optimise image processing. The annual recruitment capacity is 50 patients; a maximum number of 30 to 40 patients is expected.
- Written consent: prospective collection of the patient's non-opposition
- Duration of each patient's participation: 1 day
- Data processing: This will be a collaborative work with the EnCoV team under the responsibility of Pr A. BARTOLI. The most relevant images will be extracted, corrected and then transformed into a 3D model in order to acquire depth data. The CT scan images will also be transformed into 3D format. These two 3D models (from the patient and from the imaging) will be merged using an algorithm, in order to allow surface registration. The data will first be stored on the EnCoV servers.
- Validation of the navigation system by experimenting it on phantom models made from 3D printing and ex vivo animal models, to form a quantitative preclinical study. In endonasal endoscopy procedures the validity of the display of easily recognisable structures will be checked.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| cohort 1 | – | –Adult patients * Admitted in the ENT and Cervico-Facial Surgery department of the Gabriel Montpied University Hospital in Clermont-Ferrand. * From November 2020 to October 2021, * Requiring endoscopic sinus surgery * With good quality imaging (CT scan and/or MRI) |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adult patients addmitted in the ENT and Cervico-Facial Surgery department of the Gabriel Montpied University Hospital in Clermont-Ferrand requiring endoscopic sinus surgery
Key inclusion criteria (5 listed)
- Adult patients
- Admitted in the ENT and Cervico-Facial Surgery department of the Gabriel Montpied University Hospital in Clermont-Ferrand.
- From November 2020 to October 2021,
- Requiring endoscopic sinus surgery
- With good quality imaging (CT scan and/or MRI)
Key exclusion criteria (1 listed)
- Patient under the age of 18
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Target registration error
Time frame: day 1
The feasibility of integrating medical imaging data with endoscopic images will be assessed by the accuracy of the registration obtained, called TRE (Target Registration Error). This is a standard evaluation methodology of a registration between modalities.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Jul 2021.
Related trials for Paranasal Sinus Diseases
Not yet recruiting
Smartphone Camera Measurement of Breathing-Related Heart Rate Variability Compared With ECG in Healthy Adults
Respiratory Sinus Arrhythmia, Heart Rate Variability
RecruitingPhase 1/2
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma
RecruitingPhase 3
A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Nasal Polyps
Active, not recruitingObservational study
Whole-Body ⁶⁸Ga-FAPI PET/CT in Cavernous Sinus Syndrome: A Prospective Comparison With ¹⁸F-FDG PET/CT
Cavernous Sinus Syndrome
RecruitingObservational study
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Justine Bécaud principal investigator
University Hospital, Clermont-Ferrand
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Paranasal Sinus Diseases and Nasal Diseases, run by University Hospital, Clermont-Ferrand at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 20 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Lise Laclautre (334.73.754.963, promo_interne_drci@chu-clermontferrand.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Target registration error (time frame: day 1). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2021.